| Financial Year |
March 31 2023 |
| Monetary Funds |
162,261,713.08 |
| Held-for-trading Financial Assets |
9,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
15,638,669.78 |
| Advances to Suppliers |
3,897,748.19 |
| Other Receivables |
16,339,161.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
30,867,893.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,552,241.53 |
| Total Current Assets |
241,557,427.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
39,071,773.14 |
| Fixed Assetes |
45,920,530.58 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
84,058.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,986,674.71 |
| Deferred Income Tax Assets |
162.22 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
112,341,205.74 |
| Total Assets |
353,898,633.59 |
| Short-Term Loans |
31,339,009.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
20,432,729.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,423,505.74 |
| Taxes Payable |
789,374.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
70,003,682.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,402,047.79 |
| Other Current Liabilities |
47,089.98 |
| Sub-Total of Current Liabilities |
125,840,399.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
117,122,527.59 |
| Deferred Income Tax Liabilities |
6,153,656.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
126,416,246.65 |
| Total Liabilities |
252,256,646.29 |
| Paid-In Capital(Or Share Stock) |
346,448,044.00 |
| Capital Surplus |
157,024,158.46 |
| Surplus Reserve |
8,998,897.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-356,202,142.51 |
| Minority Stockholder's Interest |
11,356,229.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
90,285,757.93 |
| Owner's Equity（Stockholder's Equity） |
101,641,987.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
353,898,633.59 |
